IPCEI Health 1

October 22, 2024

FORM FACILITATION

Contribution/Repayable fund

REGIONS

Piedmont, Lombardy, Valle d'Aosta/Vallée d'Aoste, Liguria, Abruzzo, Molise, Basilicata, Calabria, Campania, Puglia, Sicily, Trentino-Alto Adige/Südtirol, Veneto, Sardinia, Tuscany, Friuli-Venezia Giulia, Emilia- Romagna, Umbria, Marche, Lazio

SECTOR

Chemical and Pharmaceutical, Health, Other services, Mechanics, ICT, Electronics

ALLOWED EXPENSE

0 €

INCENTIVE STATUS

ACTIVE

OPENING DATE

CLOSING DATE

October 15, 2024
December 13, 2024

NOTES

The Directorial Decree of 24 September 2024 - IPCEI Salute 1 (Med4Cure) defines, in implementation of the ministerial decree of 3 July 2024, the methods and terms for sending requests for facilitation relating to IPCEI Salute 1, as well as the forms, procedures details for the granting and disbursement of benefits and further elements suitable for allowing the correct implementation of the relief interventions.

Share fact sheet

Things

IPCEI Salute 1 supports research, innovation and the first industrial application of healthcare products, as well as innovative drug production processes. IPCEI Med4Cure covers research and development projects covering all key stages of the pharmaceutical value chain, from the collection and study of cells, tissues and other samples, to sustainable manufacturing technologies for innovative therapies, including personalized treatments, and to the application of advanced digital technologies. The project aims to accelerate medical progress and promote the resilience of the EU healthcare industry by improving drug discovery, in particular for unmet medical needs such as rare diseases, and by developing innovative and more sustainable production processes for medicines. These developments will improve the quality of healthcare and increase the EU's preparedness for emerging health threats, while contributing to the green transition. 

Who is it aimed at?

The tender and the related resources are intended exclusively for companies that have already received the specific decision authorizing the aid from the EC on 28 May 2024. Applications presented by companies that have not already obtained the aforementioned authorization are therefore not eligible. 

What does it predict

Granting of Fund benefits to entities implementing the project, authorized pursuant to European Commission Decision C(2024) 3629 final of 28 May 2024. 

Objective – Purpose

Innovation and research, Investment support

Form – Facilitation

Contribution/Repayable fund

Maximum Allowable Expenditure

30000000 €

Allowed Costs

Buildings and land, Personnel costs, Raw materials, consumables and goods, General expenses/other charges, Plant/Machinery/Equipment, Services, patents and licenses

Maximum grantable benefit

25000000 €
Subject type
Business

Dimension

Micro-enterprise, Medium-sized enterprise, Large enterprise, Unclassifiable/classified, Small enterprise

Activity sector

Chemical and Pharmaceutical, Health, Other services, Mechanics, ICT, Electronics

ATECO

All economic sectors eligible to receive aid

Regions

Piedmont, Lombardy, Valle d'Aosta/Vallée d'Aoste, Liguria, Abruzzo, Molise, Basilicata, Calabria, Campania, Puglia, Sicily, Trentino-Alto Adige/Südtirol, Veneto, Sardinia, Tuscany, Friuli-Venezia Giulia, Emilia- Romagna, Umbria, Marche, Lazio

Managing entity

Ministry of Business and Made in Italy

Primary regulatory basis

Decree of the Minister of Economic Development in agreement with the Minister of Economy and Finance - IPCEI Fund. General criteria for the intervention and functioning of the Fund

Implementation measure

Decree of the Minister of Economic Development in agreement with the Minister of Economy and Finance - IPCEI Fund. General criteria for the intervention and functioning of the Fund

Incentive allocation

194631620.72 €

Reference site

https://www.mimit.gov.it/it/incentivi/ipcei-salute-1-med4cure

Is this the right announcement for you?

Let's find out together, fill out the form and request a free consultation